PSA screening and prostate cancer mortality

BACKGROUND: Physicians have speculated that prostate-specific antigen (PSA) screening may be responsible for the reduction in prostate cancer mortality observed in the late 1990s. In order to test this hypothesis, we assessed the relation between the change in prostate cancer incidence in the early...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perron, Linda, Moore, Lynne, Bairati, Isabelle, Bernard, Paul-Marie, Meyer, François
Format: Artigo
Idioma:Inglês
Publicat: 2002
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC99399/
https://ncbi.nlm.nih.gov/pubmed/11898936
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars